
BIOVERSE Asia 2026
Opis
"Transforming drug discovery from early research to clinical application"
Najważniejsze punkty
Integration of AI and advanced technologies across drug discovery and development. Exploration of multi-omic insights driving digital discovery. Sessions on bio-discovery through AI. Discussion on next-generation R&D technologies. Focus on digital health and the future of AI in biological research. Designed for scientific and technology leaders advancing drug discovery. Opportunities for networking with over 20 speakers and 7+ hours of networking. Poster presentations and exhibitions of products & technology. Confirmed speakers include Rafik Fellague-Chebra from Novartis and Michael Winther from Engine Biosciences. Venue details to be announced; event to be held in Singapore.
Lokalizacja wydarzenia
Daj swojej sieci znać, że idziesz
Udostępnij to wydarzenie, aby rozpocząć rozmowy, zaprosić kolegów i nawiązać kontakty przed jego rozpoczęciem.
